Trials / Sponsors / Meridigen Biotech Co., Ltd.
Meridigen Biotech Co., Ltd.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS) Acute Respiratory Distress Syndrome | Phase 1 | 2024-01-01 |
| Unknown | Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). Osteoarthritis, Knee | Phase 1 | 2022-09-15 |
| Unknown | Mesenchymal Stem Cells for The Treatment of Frailty Syndrome Frailty Syndrome | Phase 1 | 2021-09-01 |
| Unknown | Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Moderate | Phase 1 | 2020-06-11 |
| Unknown | Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke Acute Ischemic Stroke | Phase 1 | 2019-12-05 |
| Recruiting | Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants Bronchopulmonary Dysplasia | Phase 1 | 2018-10-26 |